Goldman Sachs Group Inc Horizon Therapeutics Public LTD CO Transaction History

Goldman Sachs Group Inc

$555 Billion
Q1 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 14, 2024	BUY	$98.98 - $115.74 $69.1 Million - $80.8 Million	698,361 New	698,361 $80.8 Million
Q3 2023 Nov 14, 2023	BUY	$98.98 - $115.74 $24 Million - $28 Million	242,244 Added 53.11%	698,361 $80.8 Million
Q2 2023 May 14, 2024	SELL	$96.34 - $112.38 $3.22 Million - $3.75 Million	-33,388 Reduced 6.82%	456,117 $46.9 Million
Q2 2023 Aug 14, 2023	SELL	$96.34 - $112.38 $3.22 Million - $3.75 Million	-33,388 Reduced 6.82%	456,117 $46.9 Million
Q1 2023 May 14, 2024	SELL	$107.32 - $113.5 $36.9 Million - $39 Million	-343,409 Reduced 41.23%	489,505 $53.4 Million

Q1 2023 May 11, 2023	SELL	$107.32 - $113.5 $36.9 Million - $39 Million	-343,409 Reduced 41.23%	489,505 $53.4 Million
Q4 2022 May 14, 2024	SELL	$62.39 - $113.8 $45.3 Million - $82.7 Million	-726,287 Reduced 46.58%	832,914 $94.8 Million
Q4 2022 Feb 13, 2023	SELL	$62.39 - $113.8 $45.3 Million - $82.7 Million	-726,287 Reduced 46.58%	832,914 $94.8 Million
Q3 2022 May 14, 2024	SELL	$58.92 - $84.67 $678,522 - $975,059	-11,516 Reduced 0.73%	1,559,201 $96.5 Million
Q3 2022 Nov 10, 2022	SELL	$58.92 - $84.67 $678,522 - $975,059	-11,516 Reduced 0.73%	1,559,201 $96.5 Million
Q2 2022 May 14, 2024	BUY	$79.4 - $116.36 $125 Million - $183 Million	1,570,717 New	1,570,717 $125 Million
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $3.11 Million - $4.56 Million	39,172 Added 2.56%	1,570,717 $125 Million
Q1 2022 May 16, 2022	BUY	$86.42 - $109.81 $69.7 Million - $88.6 Million	806,517 Added 111.24%	1,531,545 $161 Million
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $6.01 Million - $7.31 Million	60,928 Added 9.17%	725,028 $78.1 Million
Q3 2021 Nov 10, 2021	BUY	$91.91 - $110.37 $61 Million - $73.3 Million	664,100 New	664,100 $72.7 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account